» Authors » P Gambert

P Gambert

Explore the profile of P Gambert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 116
Citations 966
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Petit J, Guiu B, Duvillard L, Jooste V, Brindisi M, Athias A, et al.
Clin Nutr . 2012 Jan; 31(4):520-5. PMID: 22209679
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. Although dietary fat contributes substantially to the accumulation of liver fat,...
2.
Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, Buffet P, et al.
Heart . 2011 Feb; 97(7):551-6. PMID: 21343169
Objective: To examine the influence of obesity on the predictive value of the pro-B-type natriuretic peptide (NT-proBNP) assay in acute myocardial infarction. Design: Prospective observational study. Setting: All intensive care...
3.
Lorgis L, Zeller M, Dentan G, Sicard P, Buffet P, LHuillier I, et al.
BMJ . 2009 May; 338:b1605. PMID: 19420032
Objective: To examine the influence of age on the predictive value of N-terminal pro-brain natriuretic (NT-proBNP) peptide assay in acute myocardial infarction. Design: Prospective observational study. Setting: All intensive care...
4.
Verges B, Florentin E, Baillot-Rudoni S, Monier S, Petit J, Rageot D, et al.
Diabetologia . 2008 Jun; 51(8):1382-90. PMID: 18535816
Aims/hypothesis: In addition to its efficacy in reducing LDL-cholesterol, rosuvastatin has been shown to significantly decrease plasma triacylglycerol. The use of rosuvastatin may be beneficial in patients with type 2...
5.
Dupuy A, Carriere I, Scali J, Cristol J, Ritchie K, Dartigues J, et al.
Climacteric . 2008 Jan; 11(1):74-83. PMID: 18202967
Objective: To evaluate plasma lipid levels in elderly women in the general population as a function of use of lipid-lowering agents (LLA) and hormone therapy (HT). Methods: A total of...
6.
Duvillard L, Caslake M, Petit J, Verges B, Gambert P, Packard C
Atherosclerosis . 2008 Jan; 199(1):27-33. PMID: 18177876
Very low density lipoprotein (VLDL) 1 and 2 were fractionated by heparin affinity chromatography into a bound and an unbound fraction and the different subfractions were quantified in 17 normolipidaemic...
7.
Persegol L, Foissac M, Lagrost L, Athias A, Gambert P, Verges B, et al.
Diabetologia . 2007 Sep; 50(11):2384-7. PMID: 17846744
Aims/hypothesis: In healthy individuals, HDL can counteract the inhibition of vasorelaxation induced by oxidised LDL. Several abnormalities such as increased size, glycation and decreased paraoxonase activity have been reported for...
8.
Dautin G, Soltani Z, Ducloux D, Gautier T, Pais de Barros J, Gambert P, et al.
Kidney Int . 2007 Aug; 72(7):871-8. PMID: 17667986
Apolipoprotein Cs (apoC-1, apoC-II, and apoC-III) are lipoprotein components that have regulatory effects on enzymes involved in lipoprotein metabolism. Owing to their low molecular weights, apoCs can adsorb onto and/or...
9.
Lorgis L, Zeller M, Dentan G, Sicard P, Jolak M, LHuillier I, et al.
QJM . 2007 Apr; 100(4):211-6. PMID: 17434911
Background: B-type natriuretic peptide and the N-terminal fragment of its prohormone, N-terminal pro-brain natriuretic peptide (Nt-proBNP), provide valuable prognostic information on short- and long-term mortality in patients with acute coronary...
10.
Galland F, Duvillard L, Petit J, Lagrost L, Vaillant G, Brun J, et al.
Diabetes Metab . 2007 Feb; 32(6):625-31. PMID: 17296517
Objective: In type 2 diabetes mellitus, oxidized LDL/LDL-Cholesterol ratio, an accurate estimation of in vivo LDL oxidation, has been reported elevated and associated with macrovascular disease. Because insulin therapy induces...